A preliminary investigation of blood cell counts for esophageal cancer screening: differentiating esophageal cancer from gastroesophageal reflux disease
Diseases of the Esophagus · 2025
DOI: 10.1093/dote/doaf025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Binrui Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, JiangYang District, Luzhou, 64600 Sichuan,…. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Esophageal Neoplasms, Early Detection of Cancer. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Esophageal Cancer (EC) ranks as the eleventh most prevalent malignancy globally and the seventh leading cause of cancer-related mortality. There is growing evidence to suggest that blood routine parameters have diagnostic and prognostic value in oncology. This study was designed to analyze whether there are any significant differences in complete blood count (CBC) parameters between patients with EC, patients with gastroesophageal reflux disease (GERD), and healthy controls (HC). We retrospectively analyzed selected blood parameters from 209 HC, 209 patients diagnosed with EC, and 198 patients suffering from GERD. We found significant differences in platelet count (PLT), mean platelet volume (MPV), plateletcrit (PCT), platelet distribution width (PDW), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) among the EC, GERD, and HC groups. Of note, PDW and LMR exhibited significant differences specifically between the EC and GERD groups. In conclusion, the LMR holds diagnostic significance and can differentiate patients with EC from those with GERD. The integration of hematological parameters and clinical manifestations serves as a guiding principle for both medical practitioners and patients in determining the necessity for upper gastrointestinal endoscopy, thereby potentially enhancing the early detection rate of EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Transfusion, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, JiangYang District, Luzhou, 64600 Sichuan, China.
- Department of Laboratory Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, No. 182 Chunhui Road, Longmatan District, Luzhou, 646000 Sichuan, China.
Zitieren
APA
Luo, B., Yang, Y., & Huang, Y. (2025). A preliminary investigation of blood cell counts for esophageal cancer screening: differentiating esophageal cancer from gastroesophageal reflux disease. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf025
Vancouver
Luo B, Yang Y, Huang Y. A preliminary investigation of blood cell counts for esophageal cancer screening: differentiating esophageal cancer from gastroesophageal reflux disease. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf025
BibTeX
@article{Luo2025,
author = {Luo, Binrui and Yang, Yang and Huang, Yuanshuai},
title = {A preliminary investigation of blood cell counts for esophageal cancer screening: differentiating esophageal cancer from gastroesophageal reflux disease},
journal = {Diseases of the Esophagus},
year = {2025},
doi = {10.1093/dote/doaf025}
}
EUVIMED